Stock PAR PHARMACEUTICAL COMPANIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Par Pharmaceutical Companies, Inc.

Equities

US69888P1066

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Par Pharmaceutical Companies, Inc.
2015 Endo : pushes further into generics with $8 billion Par Pharma buy RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Endo : pushes further into generics with $8 billion Par Pharma buy
RE
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Lamictal® XR
PU
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets
PU
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Atacand HCT®
PU
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Symbyax®
PU
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Acquires Rights To Market And Distribute Generic Seroquel Xr® In The U.S.
PU
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Receives Final Approval to Market Tretinoin Capsules
PU
Par Pharmaceutical Companies, Inc. : Par Announces Completion Of Acquisition By TPG
PR
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Companies Announces The Expiration Of The "Go Shop" Period, Receipt Of Early Termination Of HSR Waiting Period And Special Meeting Date
PR
Par Pharmaceutical Companies, Inc. : Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Par Pharmaceutical Companies, Inc.
BU
Par Pharmaceutical Companies, Inc. : Ryan & Maniskas, LLP Announces Investigation of Par Pharmaceutical Companies Inc.
BU
Par Pharmaceutical Companies, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
PR
Par Pharmaceutical Companies, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Par Pharmaceuticals Companies, Inc.
BU
Par Pharmaceutical Companies, Inc. : Law Firm Brower Piven Announces Investigation in Connection With Par Pharmaceutical Companies, Inc. Buyout
BU
Par Pharmaceutical Companies, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Par Pharmaceuticals Companies, Inc.
PR
Par Pharmaceutical Companies, Inc. : Law Offices of Howard G. Smith Announces Investigation of Par Pharmaceuticals Cos.
BU
Par Pharmaceutical Companies, Inc. : Ryan & Maniskas, LLP Announces Investigation of Par Pharmaceutical Companies Inc.
BU
Par Pharmaceutical Companies, Inc. : Pomerantz Law Firm Investigates Claims on Behalf of Investors of Par Pharmaceutical Companies
BU
Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Companies Enters Into Definitive Agreement To Be Acquired By TPG
PR
Par Pharmaceutical Companies, Inc. : Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Par Pharmaceutical Companies, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW